Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis

被引:26
作者
Dornbusch, HJ [1 ]
Strenger, V [1 ]
Kerbl, R [1 ]
Lackner, H [1 ]
Schwinger, W [1 ]
Sovinz, P [1 ]
Urban, C [1 ]
机构
[1] Karl Franzens Univ Graz, Dept Paediat & Adolescence Med, Div Paediat Haematol Oncol, A-8036 Graz, Austria
关键词
antilymphocyte antibodies; fever; procalcitonin; CRP; sepsis;
D O I
10.1038/sj.bmt.1704265
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Treatment with antibodies against T-lymphocytes usually triggers a febrile response potentially mimicking or masking infection. Procalcitonin (PCT) is considered a sensitive and specific marker of systemic bacterial and fungal infection. It was the aim of this study to investigate the characteristics of PCT and C-reactive protein (CRP) during treatment with polyclonal or monoclonal anti-T-cell antibodies, in order to examine the ability of these parameters to distinguish between systemic bacterial infection and reaction to antibody treatment. Thus, 15 consecutive febrile episodes after T-cell antibody infusion without clinical signs of infection were compared with nine episodes of Gram-negative sepsis. After T-cell antibody infusion PCT and CRP serum levels increased to a similar extent as in Gram-negative sepsis. Therefore, during T-cell antibody treatment neither PCT nor CRP are adequate for differentiating between fever due to infection or to unspecific cytokine release.
引用
收藏
页码:941 / 945
页数:5
相关论文
共 13 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[3]  
Dearden C, 1998, BRIT J HAEMATOL, V103, P846
[4]  
DORNBUSCH HJ, 2000, ACTA CHIR AUSTRIACA, V32, P37
[5]  
Eberhard OK, 1998, CLIN TRANSPLANT, V12, P206
[6]   Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II [J].
Fleischhack, G ;
Kambeck, I ;
Cipic, D ;
Hasan, C ;
Bode, U .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1093-1102
[7]   SEPSIS TERMINOLOGY IN PEDIATRICS [J].
HAYDEN, WR .
JOURNAL OF PEDIATRICS, 1994, 124 (04) :657-658
[8]   Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease [J].
Kuse, ER ;
Jaeger, K .
TRANSPLANT INTERNATIONAL, 2001, 14 (01) :55-55
[9]   Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs [J].
Lacour, AG ;
Gervaix, A ;
Zamora, SA ;
Vadas, L ;
Lombard, PR ;
Dayer, JM ;
Suter, S .
EUROPEAN JOURNAL OF PEDIATRICS, 2001, 160 (02) :95-100
[10]   C-reactive protein serum level is a valuable and simple prognostic marker in norm Hodgkin's lymphoma [J].
Legouffe, E ;
Rodriguez, C ;
Picot, MC ;
Richard, B ;
Klein, B ;
Rossi, JF ;
Commes, T .
LEUKEMIA & LYMPHOMA, 1998, 31 (3-4) :351-357